Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

CML Patients Who Fail to Achieve ≤ 1% BCR::ABL1 at 12 Months or ≤ 0.1% BCR::ABL1 at 24 Months (major molecular response, MMR) Show Significantly Inferior Survival, but Not Due to CML-Related Deaths: Data from an Italian Real-Life Observational Study

Blood (2024) 144 (Supplement 1): 3155.

https://doi.org/10.1182/blood-2024-207877

Published: 2024

Journal Articles

Evidence-Based Choice of Conditioning Regimen for Hematopoietic Stem Cell Transplantation (HSCT) in Acute Leukemia: The Italian Cellular Therapy and Stem Cell Transplant Group (GITMO) Guidelines

Blood (2024) 144 (Supplement 1): 2126.

https://doi.org/10.1182/blood-2024-204924

Published: 2024

Journal Articles

Baseline Characteristics from Arise Study, an Italian Non-Interventional Study Assessing the Real-World Use of Acalabrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

Blood (2024) 144 (Supplement 1): 7747.

https://doi.org/10.1182/blood-2024-199041

Published: 2024

Journal Articles

Salvage Transplant Versus CAR-T Cell Therapy for Relapsed Multiple Myeloma

Blood (2023) 142 (Supplement 1): 3592.

https://doi.org/10.1182/blood-2023-184945

Published: 2023

Journal Articles

A Snapshot of the Management of Chronic Lymphocytic Leukemia in Italy. Preliminary Analysis on over 3000 Patients Enrolled in the Gimema CLL2121 Trial

Blood (2023) 142 (Supplement 1): 6544.

https://doi.org/10.1182/blood-2023-188454

Published: 2023

Journal Articles

Description of a Clinical Score to Identify PMBL Patients at High Risk of Early-Failure after Rituximab Doxorubicin Back-Bone Chemoimmunotherapy. a FIL Real-World Study

Emilio Iannitto, Monica Balzarotti, Maurizio Martelli, Pier Luigi Zinzani, Alessandra Tucci, Alice Di Rocco, Federica Cavallo, Sara Usai, Anna Guidetti, Emanuele Ravano, Franceso Merli, Barbara Botto, Matteo Pelosini, Cristina Tecchio, Michele Spina, Enrico Derenzini, Silvia Finotto, Brunella Mola, Antonio Pinto, Manuela Zanni, Roberta Battistini, Stefan Hohaus, Irene Dogliotti, Guido Gini, Vittorio Ruggero Zilioli, Sonya De Lorenzo, Anna Dodero, Alessandro Broccoli, Alessandro Maggi, Clara Mannarella, Annalisa Chiarenza, Domenico Pastore, Pellegrino Musto, Caterina Stelitano, Francesco Di Raimondo, Nicola Cascavilla, Nicola Di Renzo, Marilena Salerno, Renato Scalone, Luca Nassi, Attilio Guarini, Caterina Patti, Vita Polizzi, Gabriella Amato, Giovannino Ciccone, Andrea Evangelista, Agostino La Porta, Angelo Genua, Donato Mannina, Ciro Maria Improta, Alessandro Re, Fabrizio Lo Presti, Rosalba Donatella Calogero, Maurizio Musso, Ugo Consoli

Blood (2023) 142 (Supplement 1): 986.

https://doi.org/10.1182/blood-2023-178197

Published: 2023

Journal Articles

The Use of 2 nd Generation TKIs As First Line Therapy Does Not Prevent CML Related Deaths: Results of an Italian CML Campus Prospective Study in 1277 Patients Treated First Line with Imatinib or 2 nd Generation TKIs

Blood (2023) 142 (Supplement 1): 3168.

https://doi.org/10.1182/blood-2023-182981

Published: 2023

Journal Articles

Minimal Residual Disease Negativity after Blinatumomab Is Predictive of Survival in B-Cell Acute Lymphoblastic Leukemia: Data from a Real-Life Study

Salvatore Leotta, Andrea Duminuco, Antonino Mulè, Stefania Tringali, Elisa Mauro, Calogero Vetro, Cinzia Maugeri, Marina Parisi, Bruno Garibaldi, Nicola Di Renzo, Claudia Romano, Domenico Pastore, Massimo Gentile, Ernesto Vigna, Carmine Selleri, Giuseppe Milone, Uros Markovic

Blood (2022) 140 (Supplement 1): 11854–11855.

https://doi.org/10.1182/blood-2022-166546

Published: 2022

Journal Articles

The Accuracy of the International Myeloma Working Group Frailty Score in Capturing Health-Related Quality of Life Profile of Patients with Relapsed Refractory Multiple Myeloma

Blood (2021) 138 (Supplement 1): 115.

https://doi.org/10.1182/blood-2021-145977

Published: 2021

Journal Articles

Adherence to Treatment in Myelofibrosis Patients: Preliminary Results from Italian Romei Observational Study

Paola Guglielmelli, MD PhD, Francesca Palandri, PhD MD, Carmine Selleri, MD, Daniela Cilloni, MD PhD, Francesco Mendicino, MD, Patrizio Mazza, MD, Domenico Pastore, MD PhD, Giuseppe A. Palumbo, MD, Sergio Siragusa, Prof, MD, Vincenzo Pavone, Stefana Impera, MD, Mara Morelli, MD, Francesco Passamonti, MD, Massimo Breccia, MD

Blood (2019) 134 (Supplement_1): 4179.

https://doi.org/10.1182/blood-2019-124730

Published: 2019

Journal Articles

Phase II Multicenter, Not Comparative, Study of Multiple Doses of NEPA (netupitant + palonosetron) in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in Non-Hodgkin Lymphoma Patients Eligible for Autologous Hematopoietic Stem Cell Transplantation Receiving Multiple Days / High Dose Chemotherapy Regimens

Nicola Di Renzo, MD, Maurizio Musso, MD, Rosanna Scimè, MD, Giuseppe Milone, MD PhD, Tommasina Perrone, MD, Clara De Risi, MD, Domenico Pastore, MD PhD, Attilio Guarini, MD, Andrea Mengarelli, MD, Fabio Benedetti, MD, Patrizio Mazza, MD, Vera Capria, MD, Patrizia Chiusolo, Luca Cupelli, MD, Vincenzo Federico, MD, Valentina Bozzoli, PhD MD, Anna Rita Messa, Giorgina Specchia, MD

Blood (2019) 134 (Supplement_1): 1974.

https://doi.org/10.1182/blood-2019-125071

Published: 2019

Journal Articles

Real-World Management of Myelofibrosis with Ruxolitinib: Initial Analysis of an Italian Observational Study (ROMEI)

Massimo Breccia, MD, Paola Guglielmelli, MD PhD, Alessandra Malato, MD, Francesco Mendicino, MD, Giuseppe A. Palumbo, MD, Carmine Selleri, MD, Daniela Cilloni, MD PhD, Patrizio Mazza, MD, Sergio Siragusa, MD Professor, Elisabetta Abruzzese, Roberto Latagliata, Monica Crugnola, MD, Domenico Pastore, MD PhD, Giorgia Micucci, MD, Giulia Benevolo, MD, Mara Morelli, MD, Francesca Palandri, PhD MD, Francesco Passamonti

Blood (2018) 132 (Supplement 1): 4312.

https://doi.org/10.1182/blood-2018-99-110198

Published: 2018

Journal Articles

Ibrutinib, Single Agent BTK Inhibitor, for Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia: A Real-Life Experience from Rete Ematologica Pugliese (REP)

Potito Rosario Scalzulli, MD, Attilio Guarini, MD, Giacomo Loseto, MD, Giorgina Specchia, Anna Maria Giordano, Domenico Pastore, MD PhD, Giovanni Quintana, MD, Patrizio Mazza, MD, Alessandro Maggi, Nicola Di Renzo, MD, Maria Rosaria De Paolis, Giuseppe Tarantini, Gaetano De Santis, MD, Vincenzo Pavone, Antonino Greco, MD, Maria Rosa Valvano, Statistician, Nicola Cascavilla, MD

Blood (2018) 132 (Supplement 1): 5557.

https://doi.org/10.1182/blood-2018-99-116441

Published: 2018

Journal Articles

Prophylaxis with ATLG Significantly Improves Chronic Graft-Versus-Host Disease / Relapse-Free Survival and Quality of Life after a Myeloablative HLA Identical Sibling Transplant for Acute Leukemia Patients in Complete Remission. Long-Term Follow-up of the Randomized ATG Familystudy

Blood (2017) 130 (Supplement 1): 519.

https://doi.org/10.1182/blood.V130.Suppl_1.519.519

Published: 2017

Journal Articles

Interaction Between Center Effect and Strategy for Graft Vs. Host Disease Prophylaxis on Outcome of T-Cell Depleted and T-Cell Replete Haploidentical Transplants, an Analysis on Behalf of ALWP-EBMT

Lucie Biard, MDMSc, Myriam Labopin, Annalisa Ruggeri, MD, Fabio Ciceri, MD, Johanna Tischer, Boris V Afanasyev, Professor, Domenico Pastore, Donald Bunjes, Gerhard Ehninger, MD, Dietrich W. Beelen, Prof. Dr. MD, Mohamad Mohty, MD PhD, Arnon Nagler, Matthieu Resche-Rigon, MD PhD

Blood (2016) 128 (22): 3488.

https://doi.org/10.1182/blood.V128.22.3488.3488

Published: 2016

Journal Articles

Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph+ Acute Lymphoblastic Leukemia

Nicoletta Coccaro, Antonella Zagaria, Luisa Anelli, Giuseppina Tota, Paola Orsini, Claudia Brunetti, Luciana Impera, Angela Minervini, Crescenzio Francesco Minervini, Cosimo Cumbo, Angelo Cellamare, Paola Casieri, Domenico Pastore, Paola Carluccio, Giorgina Specchia, Francesco Albano, MD

Blood (2015) 126 (23): 4989.

https://doi.org/10.1182/blood.V126.23.4989.4989

Published: 2015

Journal Articles

Bloodstream Infections Caused By Klebsiella Pneumoniae in Onco-Hematological Patients: Incidence and Clinical Impact of Carbapenem Resistance in a Multicentre Prospective Survey

Enrico Maria Trecarichi, MD, Mario Tumbarello, MD, Roberta Di Blasi, MD, Luana Fianchi, Simona Sica, Bruno Martino, MD, Anna Candoni, MD, Gianpaolo Nadali, MD, Domenico Pastore, Vincenzo Perriello, MD, Alessandro Busca, MD, Franco Aversa, MD, Rosa Fanci, MD, Lorella Melillo, MD, Federica Lessi, MD, Maria Ilaria Del Principe, MD, Chiara Cattaneo, Livio Pagano

Blood (2015) 126 (23): 3757.

https://doi.org/10.1182/blood.V126.23.3757.3757

Published: 2015

Journal Articles

Lymphoid Enhancer Binding Factor-1 (LEF1) Expression As a Prognostic Factor In Adult Acute Promyelocytic Leukemia

Francesco Albano, Luisa Anelli, Antonella Zagaria, Crescenzio Francesco Minervini, Paola Orsini, Luciana Impera, Paola Casieri, Angela Minervini, Giuseppina Tota, Domenico Pastore, Paola Carluccio, Angelo Cellamare, Claudia Brunetti, Nicoletta Coccaro, Giorgina Specchia

Blood (2013) 122 (21): 1306.

https://doi.org/10.1182/blood.V122.21.1306.1306

Published: 2013

Journal Articles

Impact of CD3/T Regs Ratio in Donor Graft On Survival Rates in Allogeneic Peripheral Blood Stem Cell Transplantation

Mario Delia, Domenico Pastore, Anna Mestice, Paola Carluccio, Tommasina Perrone, Francesco Gaudio, Paola Curci, Alessandra Ricco, Antonella Russo Rossi, Annamaria Giordano, Vera Carluccio, Ilaria Di Tardo, Rosa Angarano, Maria Chiara Longo, Giorgina Specchia

Blood (2012) 120 (21): 2030.

https://doi.org/10.1182/blood.V120.21.2030.2030

Published: 2012

Journal Articles

The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation

Francesco Albano, Antonella Zagaria, Luisa Anelli, Nicoletta Coccaro, Giuseppina Tota, Angela Minervini, Luciana Impera, Crescenzio Francesco Minervini, Alessandra Ricco, Domenico Pastore, Mario Delia, Paola Casieri, Giorgina Specchia

Blood (2012) 120 (21): 5058.

https://doi.org/10.1182/blood.V120.21.5058.5058

Published: 2012

NARROW

CML Patients Who Fail to Achieve ≤ 1% BCR::ABL1 at 12 Months or ≤ 0.1% BCR::ABL1 at 24 Months (major molecular response, MMR) Show Significantly Inferior Survival, but Not Due to CML-Related Deaths: Data from an Italian Real-Life Observational Study

Evidence-Based Choice of Conditioning Regimen for Hematopoietic Stem Cell Transplantation (HSCT) in Acute Leukemia: The Italian Cellular Therapy and Stem Cell Transplant Group (GITMO) Guidelines

Baseline Characteristics from Arise Study, an Italian Non-Interventional Study Assessing the Real-World Use of Acalabrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

Salvage Transplant Versus CAR-T Cell Therapy for Relapsed Multiple Myeloma

A Snapshot of the Management of Chronic Lymphocytic Leukemia in Italy. Preliminary Analysis on over 3000 Patients Enrolled in the Gimema CLL2121 Trial

Description of a Clinical Score to Identify PMBL Patients at High Risk of Early-Failure after Rituximab Doxorubicin Back-Bone Chemoimmunotherapy. a FIL Real-World Study

The Use of 2 nd Generation TKIs As First Line Therapy Does Not Prevent CML Related Deaths: Results of an Italian CML Campus Prospective Study in 1277 Patients Treated First Line with Imatinib or 2 nd Generation TKIs

Minimal Residual Disease Negativity after Blinatumomab Is Predictive of Survival in B-Cell Acute Lymphoblastic Leukemia: Data from a Real-Life Study

The Accuracy of the International Myeloma Working Group Frailty Score in Capturing Health-Related Quality of Life Profile of Patients with Relapsed Refractory Multiple Myeloma

Adherence to Treatment in Myelofibrosis Patients: Preliminary Results from Italian Romei Observational Study

Real-World Management of Myelofibrosis with Ruxolitinib: Initial Analysis of an Italian Observational Study (ROMEI)

Ibrutinib, Single Agent BTK Inhibitor, for Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia: A Real-Life Experience from Rete Ematologica Pugliese (REP)

Prophylaxis with ATLG Significantly Improves Chronic Graft-Versus-Host Disease / Relapse-Free Survival and Quality of Life after a Myeloablative HLA Identical Sibling Transplant for Acute Leukemia Patients in Complete Remission. Long-Term Follow-up of the Randomized ATG Familystudy

Interaction Between Center Effect and Strategy for Graft Vs. Host Disease Prophylaxis on Outcome of T-Cell Depleted and T-Cell Replete Haploidentical Transplants, an Analysis on Behalf of ALWP-EBMT

Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph+ Acute Lymphoblastic Leukemia

Bloodstream Infections Caused By Klebsiella Pneumoniae in Onco-Hematological Patients: Incidence and Clinical Impact of Carbapenem Resistance in a Multicentre Prospective Survey

Lymphoid Enhancer Binding Factor-1 (LEF1) Expression As a Prognostic Factor In Adult Acute Promyelocytic Leukemia

Impact of CD3/T Regs Ratio in Donor Graft On Survival Rates in Allogeneic Peripheral Blood Stem Cell Transplantation

The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only